{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:03:51Z","timestamp":1792785831500,"version":"4.5.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K07145"],"award-info":[{"award-number":["16K07145"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS Grant-in-Aid for Young Scientists","award":["16K18423"],"award-info":[{"award-number":["16K18423"]}]},{"DOI":"10.13039\/100015644","name":"Pancreas Research Foundation of Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015644","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sapporo Jikeikai Tomoiki Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,21]]},"DOI":"10.1093\/carcin\/bgy075","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T15:09:04Z","timestamp":1527606544000},"page":"1127-1134","source":"Crossref","is-referenced-by-count":15,"title":["MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer"],"prefix":"10.1093","volume":"39","author":[{"given":"Keisuke","family":"Ishigami","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Nosho","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":",Hideyuki","family":"Koide","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Mitsuhashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayoshi","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Shitani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Motoya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutoshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Surgical Oncology and Science, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kaneto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Muroran City General Hospital, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Takemasa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Surgical Oncology and Science, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Sapporo Medical University School of Medicine, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakase","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Chuo-ku, Sapporo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"key":"key\n\t\t\t\t20180921080201_CIT0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5009\/gnl15568","article-title":"Cholangiocarcinoma: current knowledge and new developments","volume":"11","author":"Blechacz","year":"2017","journal-title":"Gut Liver"},{"key":"key\n\t\t\t\t20180921080201_CIT0002","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180921080201_CIT0003","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180921080201_CIT0004","first-page":"227","article-title":"Epigenetic alterations associated with cholangiocarcinoma (review)","volume":"22","author":"Isomoto","year":"2009","journal-title":"Oncol. Rep"},{"key":"key\n\t\t\t\t20180921080201_CIT0005","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1038\/sj.onc.1210228","article-title":"MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma","volume":"26","author":"Szafranska","year":"2007","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180921080201_CIT0006","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1053\/j.gastro.2006.02.057","article-title":"Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines","volume":"130","author":"Meng","year":"2006","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180921080201_CIT0007","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00535-016-1178-0","article-title":"A micro-RNA expression signature for human NAFLD progression","volume":"51","author":"Guo","year":"2016","journal-title":"J. Gastroenterol"},{"key":"key\n\t\t\t\t20180921080201_CIT0008","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00535-016-1161-9","article-title":"The role of microRNA in esophageal squamous cell carcinoma","volume":"51","author":"Harada","year":"2016","journal-title":"J. Gastroenterol"},{"key":"key\n\t\t\t\t20180921080201_CIT0009","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/carcin\/bgx026","article-title":"Small non-coding RNA and cancer","volume":"38","author":"Romano","year":"2017","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20180921080201_CIT0010","article-title":"Development of novel therapeutic agents by inhibition of oncogenic microRNAs","volume":"19: 65","author":"Nguyen","year":"2017","journal-title":"Int. J. Mol. Sci"},{"key":"key\n\t\t\t\t20180921080201_CIT0011","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/carcin\/bgt374","article-title":"Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway","volume":"35","author":"Nosho","year":"2014","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20180921080201_CIT0012","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.18632\/oncotarget.3109","article-title":"Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis","volume":"6","author":"Mitsuhashi","year":"2015","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180921080201_CIT0013","doi-asserted-by":"crossref","first-page":"12704","DOI":"10.18632\/oncotarget.7260","article-title":"The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway","volume":"7","author":"Kurihara","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180921080201_CIT0014","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mc.21864","article-title":"Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance","volume":"52","author":"Karakatsanis","year":"2013","journal-title":"Mol. Carcinog"},{"key":"key\n\t\t\t\t20180921080201_CIT0015","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3892\/etm.2013.1311","article-title":"miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1","volume":"6","author":"Hu","year":"2013","journal-title":"Exp. Ther. Med"},{"key":"key\n\t\t\t\t20180921080201_CIT0016","doi-asserted-by":"crossref","first-page":"e0157140","DOI":"10.1371\/journal.pone.0157140","article-title":"Expression of molecular differentiation markers does not correlate with histological differentiation grade in intrahepatic cholangiocarcinoma","volume":"11","author":"Demarez","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180921080201_CIT0017","first-page":"1","article-title":"Clinical significance of soluble intercellular adhesion molecule-1 and interleukin-6 in patients with extrahepatic cholangiocarcinoma","author":"Shimura","year":"2017","journal-title":"J Invest. Surg"},{"key":"key\n\t\t\t\t20180921080201_CIT0018","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12032-015-0553-7","article-title":"Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis","volume":"32","author":"Zhou","year":"2015","journal-title":"Med. Oncol"},{"key":"key\n\t\t\t\t20180921080201_CIT0019","first-page":"58","article-title":"Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer","volume":"1","author":"Johnson","year":"2012","journal-title":"Transl. Gastrointest. Cancer"},{"key":"key\n\t\t\t\t20180921080201_CIT0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gutjnl-2011-300643","article-title":"Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism","volume":"61","author":"Frampton","year":"2012","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180921080201_CIT0021","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1038\/ncomms8652","article-title":"NF-\u03baB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis","volume":"6","author":"Yan","year":"2015","journal-title":"Nat. Commun"},{"key":"key\n\t\t\t\t20180921080201_CIT0022","article-title":"Stress responsive miR-31 is a major modulator of mouse intestinal stem cells during regeneration and tumorigenesis","volume":"6: e29538","author":"Tian","year":"2017","journal-title":"Elife"},{"key":"key\n\t\t\t\t20180921080201_CIT0023","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12032-009-9269-x","article-title":"Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance","volume":"27","author":"Zhang","year":"2010","journal-title":"Med. Oncol"},{"key":"key\n\t\t\t\t20180921080201_CIT0024","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/CS20110207","article-title":"The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma","volume":"121","author":"Zhang","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"key\n\t\t\t\t20180921080201_CIT0025","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41467-017-01059-5","article-title":"MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists","volume":"8","author":"Lv","year":"2017","journal-title":"Nat. Commun"},{"key":"key\n\t\t\t\t20180921080201_CIT0026","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1074\/jbc.M112.367763","article-title":"MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1)","volume":"288","author":"Sun","year":"2013","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180921080201_CIT0027","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"issue":"4 Pt B","key":"key\n\t\t\t\t20180921080201_CIT0028","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.bbadis.2017.08.020","article-title":"Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma","volume":"1864","author":"Chung","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20180921080201_CIT0029","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study","volume":"128","author":"Shaib","year":"2005","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180921080201_CIT0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.22606","article-title":"Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans","volume":"49","author":"El-Serag","year":"2009","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180921080201_CIT0031","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1023\/A:1013747228572","article-title":"Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy","volume":"12","author":"Donato","year":"2001","journal-title":"Cancer Causes Control"},{"key":"key\n\t\t\t\t20180921080201_CIT0032","doi-asserted-by":"crossref","first-page":"149185","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J. Immunol. Res"},{"key":"key\n\t\t\t\t20180921080201_CIT0033","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1038\/ncomms8639","article-title":"MicroRNA-31 negatively regulates peripherally derived regulatory T-cell generation by repressing retinoic acid-inducible protein 3","volume":"6","author":"Zhang","year":"2015","journal-title":"Nat. Commun"},{"key":"key\n\t\t\t\t20180921080201_CIT0034","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ni.3755","article-title":"The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection","volume":"18","author":"Moffett","year":"2017","journal-title":"Nat. Immunol"},{"key":"key\n\t\t\t\t20180921080201_CIT0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2007.12.020","article-title":"Autocrine IL-6 signaling: a key event in tumorigenesis","volume":"13","author":"Grivennikov","year":"2008","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20180921080201_CIT0036","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol"},{"key":"key\n\t\t\t\t20180921080201_CIT0037","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00109-013-1080-7","article-title":"The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications\u2014a review","volume":"91","author":"Macci\u00f2","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"key":"key\n\t\t\t\t20180921080201_CIT0038","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-013-2488-z","article-title":"The role of intratumoral and systemic IL-6 in breast cancer","volume":"138","author":"Dethlefsen","year":"2013","journal-title":"Breast Cancer Res. Treat"},{"key":"key\n\t\t\t\t20180921080201_CIT0039","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-12-26","article-title":"IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus","volume":"12","author":"Chen","year":"2013","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t20180921080201_CIT0040","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.7150\/ijbs.4614","article-title":"Interleukin-6\u2014a key regulator of colorectal cancer development","volume":"8","author":"Waldner","year":"2012","journal-title":"Int. J. Biol. Sci"},{"key":"key\n\t\t\t\t20180921080201_CIT0041","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2011.05.033","article-title":"Interleukin-6: a multifunctional targetable cytokine in human prostate cancer","volume":"360","author":"Culig","year":"2012","journal-title":"Mol. Cell. Endocrinol"},{"key":"key\n\t\t\t\t20180921080201_CIT0042","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180921080201_CIT0043","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1593\/neo.13706","article-title":"The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis","volume":"15","author":"Chang","year":"2013","journal-title":"Neoplasia"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/39\/9\/1127\/25820905\/bgy075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T11:58:17Z","timestamp":1589889497000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/39\/9\/1127\/5025674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,5,30]]},"published-print":{"date-parts":[[2018,9,21]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgy075","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2018,5,30]]}}}